The largest database of trusted experimental protocols

Synergy 2 luminometer

Manufactured by Agilent Technologies
Sourced in United States

The Synergy 2 luminometer is a compact and versatile instrument designed for sensitive detection of luminescent signals. It utilizes advanced optics and sensitive photon-counting technology to enable accurate and reliable luminescence measurements. The Synergy 2 is capable of performing a range of luminescence-based assays, making it a suitable tool for various applications in life science research and analytical laboratories.

Automatically generated - may contain errors

33 protocols using synergy 2 luminometer

1

Quantification of PTHrP Promoter Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PTHrP-P3 plasmid, containing the 140 bp upstream of the P3 TATA box, was cloned into the pGL-2 vector and obtained from Cataisson et al13 The AR42J cells were transfected with the PTHrP plasmid or empty vector (control), and co-transfected with a Renilla luciferase construct via electroporation.8 (link) After experimental treatments, cell lysates were prepared following the Dual-Luciferase Reporter (Promega; Madison, Wis). Luciferase activity was quantitated, in triplicate, using a Synergy 2luminometer (BioTek, Winooski, Vt). Readings for the empty vector were subtracted from their corresponding luciferase values. The firefly luciferase activity was normalized to Renilla luciferase activity and the fold differences were plotted as the firefly/Renilla ratio.
+ Open protocol
+ Expand
2

Quantifying Total and HEL-Specific IgM in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total and HEL specific IgM in plasma were measured by ELISA. Briefly, 96-well white round-bottomed MicroFluor microtiter plates (Thermo Lab systems) plates were coated with either 5 µg/ml of an anti-mouse IgM (Sigma; M8644) or with 1 µg/ml of HEL (Sigma) in DPBS overnight and then washed 3 times with PBS/EDTA and blocked with Tris-buffered saline containing 1% BSA (TBS/BSA) for 1 h at room temperature. After washing the plates as before, diluted murine plasma was added in TBS/BSA to the wells and incubated for 1 hour at room temperature. Plates were washed and bound total or HEL-specific IgM were detected with an anti-mouse IgM antibody conjugated to alkaline phosphatase (Sigma; A9688). Wells were washed again as before and rinsed once with distilled water, and 25 µl of a 30% LumiPhos Plus solution in dH20 (Lumigen Inc) was added. After 75 min the light emission was measured with a Synergy 2 luminometer (BIO-TEK) and expressed as RLU per 100ms.
+ Open protocol
+ Expand
3

Proteasome Chymotrypsin-like Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chymotrypsin-like activity of the proteasome after treatment with the above-mentioned proteasome inhibitors was measured using the luminescence-based Proteasome-Glo assay (Promega). Cells were plated in 96-well flat-bottomed plates (Perkin Elmer), cultured for 24 h and then incubated for 2 h with the respective compounds at indicated concentrations or DMSO-only solvent control. A peptide substrate for the chymotrypsin-like activity of the proteasome conjugated to recombinant luciferase, Suc-LLVY-(succinyl-leucine-leucine-valine-tyrosine-)aminoluciferin, was added for 10 minutes, before luminescence was measured with a BioTek Synergy 2 Luminometer (BioTek). Data were normalized to the DMSO-only control group.
+ Open protocol
+ Expand
4

Hypoxia and VEGF Promoter Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIF-1α binding hypoxia-response element (HRE) and VEGF promoter containing luciferase vector (HRE-Luc and VEGF-Luc) were kind gifts from Dr. Jong-Wan Park (Seoul National University) [38 (link)]. For luciferase assay, luciferase and β-gal vector were transiently transfected into HEK293 or Caki-1 cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) and PolyFect transfection reagent (Qiagen, Venlo, Netherlands). After hypoxia or drug treatment in transfected cells, luciferase activities were measured using a Synergy 2 Luminometer (BioTek, Winooski, VT, USA) and normalized by β-gal assay.
+ Open protocol
+ Expand
5

Quantifying PPARα Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Activation of PPARα was quantified by a human PPARα reporter assay (Indigo Biosciences, State College, PA, USA) according to the manufacturer's instructions. Briefly, overexpressed PPARα reporter cells were dispensed into a 96-well plate, then immediately dosed with AM6545 and/or synthetic agonist GW590735. Following 22 h of incubation, the treatment media were discarded and luciferase detection reagent was added. The light emission intensity from the ensuing luciferase reaction was quantified after 15 min using a BioTek Synergy 2 luminometer; it was directly proportional to the relative level of PPARα activation in the reporter cells. DMSO levels were equal in all of the samples and never exceeded 0.1%. The results are reported as the percent activation compared to DMSO-only controls.
+ Open protocol
+ Expand
6

Screening Natural Compounds for β-Catenin Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
To screen single compounds derived from natural products which attenuate β-catenin/TCF4 transcriptional activity, TOP and FOP flash luciferase plasmids (100 ng/mL) were transiently transfected into HEK293T cells with ectopic expression of pBABE-puro-LEF1 (1 μg/mL), pcDNA-Myc-TCF4 (0.5 μg/mL), and pcDNA3-β-catenin (0.5 μg/mL). The transfected HEK293T cells were seeded in 96-well culture dishes and incubated for 24 h to allow stabilization and protein expression. After incubation, cells were incubated with a natural compound library containing 502 single compounds at 5 μM of final concentration for 24 h. To measure β-catenin/TCF4 transcriptional activity in A375 melanoma cells, TOP and FOP flash luciferase plasmids (0.5 μg/mL) were transiently transfected using Lipofectamine 2000 without co-transfection of pBABE-puro-LEF1, pcDNA-Myc-TCF4, and pcDNA3-β-catenin. Luciferase activities were analyzed by using a Luciferase assay system (Promega, Madison, WI, USA) and Synergy 2 Luminometer (BioTek, Winooski, VT, USA), and then luciferase activities were normalized to the activity of β-galactosidase.
+ Open protocol
+ Expand
7

Caspase-3/7 Activity Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Caspase-Glo 3/7 Assay (Promega) was performed according to manufacturer’s instructions. Briefly, purified B cells were plated in IMDM medium at the concentration of 100,000 cells/100 μl with stimuli [AffiniPure F(ab′)2 Fragment Goat Anti-Mouse IgM, μ Chain Specific (Jackson ImmunoResearch), mouse anti-CD40 (1 µg/ml, Becton Dickinson), and CXCL12 (25 nM, Peprotech)] for 24 h or left untreated. After stimulation, cells were counted and plated at 20,000/well in a white-walled multiwell plate. An equal volume of Caspase-Glo 3/7 Reagent was added to each well for 30 min. Luminescense signal was acquired on a Biotek Synergy 2 luminometer. Background readings were determined from wells containing culture medium without cells.
+ Open protocol
+ Expand
8

miR-181a-5p Luciferase Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCT-DK cells, that do not express miR-181a-5p, were seeded at a density of 80,000 cells/well in 24-well plates with complete McCoy's 5A supplemented with 10% fetal calf serum without antibiotics. The following day, cells were co-transfected with miR-181a-5p (both pMIR-REPORT plasmids -1000 ng/well- wild type or mutated for the miR-181a-5p seed site) or SCR precursor, and 100 ng/well of renilla luciferase control plasmid (pRL-TK; Promega, Madison, WI) using Lipofectamine LTX (Life Technologies,Madrid, Spain) according to the manufacturer's instructions. Luciferase assays were performed as previously described [40] .The enzymatic activities of renilla and firefly luciferases were quantified in a Synergy 2 luminometer (Biotek, Winooski, VT). Each combination of pMIR-REPORT (wild-type and mutated 3′UTR) and pRL-TK was tested in triplicate in five independent experiments. Firefly luciferase activity was normalized to renilla luciferase activity for each transfected well. The normalized data were expressed as changes relative to the data of the cells transfected with 100 nM miR-181a-5p mimic, SCR was taken as 100%.
+ Open protocol
+ Expand
9

Screening Natural Compounds for SREBP2 Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luciferase assay was performed as previously described [1 (link)]. HEK293T cells transiently transfected with steroid responsive element (SRE)-wild type (WT) or -mutant (Mut) containing luciferase vector (pSynSRE-T-Luc and pSynSRE-Mut-T-Luc) by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). pSynSRE-T-Luciferase vectors (Addgene plasmid #60444 and #60490) were gifts from Timothy Osborne [66 ]. To screen the SREBP2 activating natural compounds, transfected HEK293T cells were incubated with a library of 502 natural compounds (20 μM of each compounds) for 24 h. Luciferase activities were analyzed by using a Synergy 2 Luminometer (BioTek, Winooski, VT, USA) and β-gal assay was used for normalization.
+ Open protocol
+ Expand
10

Quantifying NF-κB Activation Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
NF-κB activity was determined by both p50 binding ELISA (Thermo Scientific) and Dual-Luciferase reporter assay (Qiagen). Binding ELISA was performed according to the manufacturer’s protocol using whole cell lysates and values were normalized to μg protein as determined by protein estimation (Pierce). Dual-Luciferase reporter assay system (Promega) results were determined by Synergy2 luminometer (Biotek).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!